ArticleRMD open2026

Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE).

Nora Vladimirova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.